QTY Trademark

Trademark Overview

On Thursday, December 8, 2016, a trademark application was filed for QTY with the United States Patent and Trademark Office. The USPTO has given the QTY trademark a serial number of 87261964. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 26, 2025. This trademark is owned by OH2 Laboratories. The QTY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Pharmaceutical drug development services
qty

General Information

Serial Number87261964
Word MarkQTY
Filing DateThursday, December 8, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 26, 2025
Registration Number5697845
Registration DateTuesday, March 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesDrug discovery services; Pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 26, 2025
Primary Code042
First Use Anywhere DateFriday, June 1, 2012
First Use In Commerce DateSunday, May 6, 2018

Trademark Owner History

Party NameOH2 Laboratories
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBerkeley, CA 94708
Party NameOH2 Laboratories
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBerkeley, CA 94708
Party NameOH2 Laboratories
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerkeley, CA 94708

Trademark Events

Event DateEvent Description
Monday, March 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 12, 2016NEW APPLICATION ENTERED
Tuesday, December 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 11, 2017ASSIGNED TO EXAMINER
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 24, 2017SOU TEAS EXTENSION RECEIVED
Friday, November 24, 2017SOU EXTENSION 1 FILED
Friday, November 24, 2017SOU EXTENSION 1 GRANTED
Tuesday, November 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 10, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, May 23, 2018TEAS STATEMENT OF USE RECEIVED
Friday, January 25, 2019REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, May 23, 2018USE AMENDMENT FILED
Tuesday, June 12, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 13, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, January 25, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 6, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 7, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 12, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 26, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

drug services development pharmaceutical discovery